Skip to main navigation Skip to search Skip to main content

Inhibition of Streptomyces hydrogenans 3α,20β-hydroxysteroid dehydrogenase by licorice-derived compounds and crystallization of an enzyme-cofactor-inhibitor complex

  • Debashis Ghosh
  • , Mary Erman
  • , Walter Pangborn
  • , William L. Duax
  • , Michael E. Baker
  • Hauptman-Woodward Medical Research Institute, Inc.
  • University of California at San Diego

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

Streptomyces hydrogenans 3α, 20β-hydroxysteroid dehydrogenase reduces the C20 ketone on glucocorticoids and progestins. We find that two licorice-derived compounds, glycyrrhizic acid and carbenoxolone, inhibit this enzyme with μM Kis. Inhibition is competitive, indicating that these compounds are binding at or close to the catalytic site. Carbenoxolone's high aqueous solubility and affinity for 3α,20β-hydroxysteroid dehydrogenase enabled us to prepare crystals of a carbenoxolone-NADH-enzyme ternary complex, which preliminary X-ray analysis indicates has a crystal structure that is significantly different from that of the 3α,20β-hydroxysteroid dehydrogenase-NADH complex. A comparison of the tertiary structures of these two complexes should prove useful in understanding this enzyme's catalytic mechanism, as well as those of two homologous enzymes, mammalian 11β-hydroxysteroid dehydrogenase and 15-hydroxyprostaglandin dehydrogenase that also are inhibited by carbenoxolone.

Original languageEnglish
Pages (from-to)849-853
Number of pages5
JournalJournal of Steroid Biochemistry and Molecular Biology
Volume42
Issue number8
DOIs
StatePublished - Sep 1992

Fingerprint

Dive into the research topics of 'Inhibition of Streptomyces hydrogenans 3α,20β-hydroxysteroid dehydrogenase by licorice-derived compounds and crystallization of an enzyme-cofactor-inhibitor complex'. Together they form a unique fingerprint.

Cite this